Physician profile
Eric Zhao
NPI 1629605753
$963.40
in general payments reported to CMS, 2019-2025
11 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $126 · 2024: $584 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $335.86 | 2023-2024 | Epclusa |
| Abbvie INC. | $137.97 | 2024 | |
| Medtronic, INC. | $117.15 | 2024-2025 | Pillcam, Barrx, Endoflip |
| Cook Medical LLC | $90.49 | 2024 | Instinct |
| Boston Scientific Corporation | $84.34 | 2025 | X-Tack Endoscopic Helix Tacking System, Axios |
| Olympus America INC. | $42.76 | 2025 | Gastrointestinal Videoscope, Endoclot Phs, Single Use Electrosurgical Hemostatic Forceps |
| Ardelyx, INC. | $42.11 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $41.25 | 2024 | Entyvio |
| Exact Sciences Corporation | $26.85 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.22 | 2025 | Jardiance |
| Vertex Pharmaceuticals Incorporated | $19.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Zhao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.